Novel transcript, antisense to ABHD11 (ENSG00000297150)

This molecule is an *antisense RNA transcript* associated with the ABHD11 gene, meaning it is transcribed from the DNA strand opposite to the sense (coding) strand of ABHD11. Antisense transcripts are widespread in the human genome and typically act as regulatory non-coding RNAs. They can affect the expression of their associated sense genes (here, ABHD11), primarily by modifying chromatin architecture, interacting with chromatin-modifying enzymes, or modulating transcription initiation, RNA processing, and stability[1][2][3]. Antisense to ABHD11 has not been directly associated with any therapeutically targeted biological pathway or disease, and there are no drugs reported to interact with this non-coding RNA. Its primary interest is likely in gene regulation research, rather than as a direct drug target. In summary, "novel transcript, antisense to ABHD11" (ENSG00000297150) is a non-coding RNA whose major role appears to be in the regulation of gene expression through chromatin modification and antisense-mediated control, but it is not a direct therapeutic target like a classic receptor or enzyme[1][2][3].

Other names

antisense to ABHD11

Not applicable for drugs; known mechanisms of antisense transcripts include modulation of chromatin state and transcription of neighboring genes[1][2][3]